Subcutaneous Insulin Use in Adults: Addressing Risks and Optimizing Safety
Insulin therapy, while essential to the health of millions of patients, continues to be a leading cause of serious patient harm when used in error. This activity will provide up-to-date information on the top insulin safety issues facing practitioners and an overview of ISMP’s newly-released national guidelines for safe subcutaneous insulin use. Expert speakers will discuss some of the unique challenges involved in managing complex insulin therapy across the continuum of care, including the use of concentrated insulins, insulin vials, and pens.
- Pharmacy Technicians
Following completion of this activity, participants will be able to:
- Describe the risks associated with subcutaneous insulin that have led to errors, as well as other preventable adverse outcomes associated with insulin management across the continuum of care.
- Compare your organization’s efforts to prevent subcutaneous insulin errors to ISMP’s Safe Practice Guidelines for Subcutaneous Insulin Use in Adults.
- Discuss three common practice concerns and reality-based solutions with insulin management across the continuum of care.
- Identify unique survival skills practitioners can teach all patients regarding subcutaneous insulin therapy.
Introduction and Overview:
Michael R. Cohen, RPh, MS, ScD (hon), DPS (hon), FASHP, President, ISMP
Complicated and Complex: Will Subcutaneous Insulin Use Ever Be Safe?
Matthew Grissinger, RPh, FISMP, FASCP, Director of Error Reporting Programs, ISMP
Recommended Subcutaneous Insulin Safe Practice Guidelines from the ISMP National Summit
Susan Paparella, MSN, RN, Vice President, ISMP
Insulin Safety: It Takes a Village
Jane Jeffrie Seley, DNP, MSN, MPH, GNP, BC-ADM, CDE, CDTC, FAADE, FAAN, Nurse Practitioner and Program Manager, Inpatient Glycemic Control Program, Weill Cornell Division of Endocrinology, Diabetes & Metabolism, New York-Presbyterian Hospital, New York, NY
This activity is funded through an educational grant from Lilly and Novo Nordisk.
Release Date: February 15, 2018
Expiration Date: February 15, 2020
Pharmacists and Pharmacy Technicians
This CE activity is jointly provided by ProCE, Inc. and ISMP. ProCE, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-18-078-H05-P/T has been assigned to this knowledge-based home-study CE activity (initial release date 2-15-18). This activity is approved for 1.5 contact hours (0.15 CEU) in states that recognize ACPE providers. This CE activity is provided at no cost to participants. Statements of completion will be issued online at www.ProCE.com upon completion of the evaluation and post-test with a score of 70% or higher. Proof of completion will be posted in NABP CPE Monitor profiles. No partial credit will be given.
This CE activity is jointly provided by ProCE, Inc. and Wild Iris Medical Education, Inc. This activity provides 1.5 contact hours of nurse CE credit. Wild Iris Medical Education, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.